Reduced gastric acidity, proton pump inhibitors and increased severity of COVID-19 infections

被引：4
|
作者：
Price, Elizabeth [1 ]
Treacher, David F. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Consultant Intens Care & Crit Care Med, London, England
来源：
CRITICAL CARE | 2021年 / 25卷 / 01期
关键词：
D O I：
10.1186/s13054-021-03497-6
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Proton Pump Inhibitors Relieve and Prevent Symptoms Related to Gastric Acidity after Esophagectomy
    Manabu Okuyama
    Satoru Motoyama
    Kiyotomi Maruyama
    Kenji Sasaki
    Yusuke Sato
    Jun-ichi Ogawa
    World Journal of Surgery, 2008, 32 : 246 - 254
  • [42] Proton pump inhibitors should be taken with meals for optimal control of gastric acidity.
    Hatlebakk, JG
    Katz, PO
    Castell, DO
    GASTROENTEROLOGY, 1998, 114 (04) : A144 - A145
  • [43] Reduced Sleep in the Week Prior to Diagnosis of COVID-19 is Associated with the Severity of COVID-19
    Huang, Baozhen
    Niu, Yanlin
    Zhao, Weiguo
    Bao, Pengtao
    Li, Diangeng
    NATURE AND SCIENCE OF SLEEP, 2020, 12 : 999 - 1007
  • [44] Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?
    Luxenburger, H.
    Sturm, L.
    Biever, P.
    Rieg, S.
    Duerschmied, D.
    Schultheiss, M.
    Neumann-Haefelin, C.
    Thimme, R.
    Bettinger, D.
    JOURNAL OF INTERNAL MEDICINE, 2021, 289 (01) : 121 - 124
  • [45] Proton Pump Inhibitor Use Is Associated with Increased Mortality in African American COVID-19 Patients
    Owings, A. H.
    Sloan, M. E.
    Liu, J. J.
    Glover, S. C.
    Abraham, G. E.
    Senitko, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [46] The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19: Hypotheses Based on Existing Evidences
    Ray, Avik
    Sharma, Swati
    Sadasivam, Balakrishnan
    DRUG RESEARCH, 2020, 70 (10) : 484 - 488
  • [47] Previous Use of Proton Pump Inhibitors (PPI) in Hospitalized Patients and COVID-19 Mortality in Peru
    Oscanoa, T. J.
    Tineo, J. A.
    Huamani, W. T.
    Perez, J. M.
    Carvajal, A.
    DRUG SAFETY, 2022, 45 (10) : 1179 - 1180
  • [48] Impact of proton pump inhibitors on the in-hospital outcome of COVID-19 patients: a retrospective study
    Yao, Haijuan
    Li, Hongyu
    Ma, Zhuang
    Wu, Yanyan
    Tang, Yufu
    Meng, Hao
    Yu, Hao
    Peng, Chengfei
    Teng, Yue
    Zhang, Quanyu
    Zhu, Tianyi
    Zhao, Haitao
    Chu, Guiyang
    Tong, Zhenhua
    Liu, Lu
    Lu, Hui
    Qi, Xingshun
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [49] Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
    Kishore, E.
    Singh, V.
    Dihowm, F.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S352 - S352
  • [50] Gastric acidity inhibitors and the risk of intestinal infections
    Canani, Roberto Berni
    Terrin, Gianluca
    CURRENT OPINION IN GASTROENTEROLOGY, 2010, 26 (01) : 31 - 35
12345